| Literature DB >> 35782070 |
Ying Yu1, Gong Zhang2, Tao Han3, Hongjie Liu4, Hailiang Huang5.
Abstract
Objective: In this study, we investigated the potential material basis of Yupingfeng powder in the prevention and treatment of 2019 novel coronavirus pneumonia (NCP) by applying molecular docking and molecular dynamic simulation technology. Design: The active ingredients and predictive targets of Yupingfeng powder were sourced using the TCMSP, ETCM, and TCMIP traditional Chinese medicine databases. NCP-related targets were then acquired from the DisGeNET and GeneCards databases, and common disease-drug targets were imported into the STRING database, and Cytoscape software was used to generate a protein-protein interaction network following the use of a network topology algorithm to identify key target genes. Gene Ontology (GO) and KEGG pathway enrichment analysis was then performed using the target genes and GOEAST and DAVID online tools. The mechanism of Yupingfeng powder in the prevention and treatment of NCP was analyzed with reference to the relevant literature. AutoDock software was used for molecular docking, the preliminary analysis of binding status, and to identify the best conformation. Desmond software was used to perform molecular dynamic simulations for protein and compound complexes, perform free energy calculations and hydrogen bond analysis, and to further verify the binding mode.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35782070 PMCID: PMC9249514 DOI: 10.1155/2022/7892397
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Main active component information of Yuping wind powder.
| Herbs | TCMSP ID | Compound | OB | DL | Targets |
|---|---|---|---|---|---|
| Fangfeng | MOL011737 | Divaricatacid | 87 | 0.32 | 5 |
| Huangqi | MOL000378 | 7-O-methylisomucronulatol | 74.69 | 0.3 | 45 |
| Huangqi | MOL000392 | Formononetin | 69.67 | 0.21 | 39 |
| Huangqi | MOL000433 | Folic acid | 68.96 | 0.71 | 3 |
| Fangfeng | MOL000011 | (2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-5-methoxy-2-methylol-2,3-dihydropyrano[5,6-h][1,4]benzodioxin-9-one | 68.83 | 0.66 | 18 |
| Huangqi | MOL000380 | (6aR,11aR)-9,10-dimethoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-ol | 64.26 | 0.42 | 22 |
| Baizhu | MOL000022 | 14-acetyl-12-senecioyl-2E,8Z,10E-atractylentriol | 63.37 | 0.3 | 1 |
| Fangfeng | MOL011732 | Anomalin | 59.65 | 0.66 | 7 |
| Huangqi | MOL000211 | Mairin | 55.38 | 0.78 | 1 |
| Baizhu | MOL000049 | 3 | 54.07 | 0.22 | 16 |
| Huangqi | MOL000371 | 3,9-Di-O-methylnissolin | 53.74 | 0.48 | 23 |
| Huangqi | MOL000239 | Jaranol | 50.83 | 0.29 | 13 |
| Fangfeng | MOL011730 | 11-Hydroxy-sec-o-beta-d-glucosylhamaudol_qt | 50.24 | 0.27 | 7 |
| Huangqi | MOL000354 | Isorhamnetin | 49.6 | 0.31 | 35 |
| Huangqi | MOL000439 | Isomucronulatol-7,2′-di-O-glucosiole | 49.28 | 0.62 | 1 |
| Huangqi | MOL000417 | Calycosin | 47.75 | 0.24 | 22 |
| Huangqi | MOL000098 | Quercetin | 46.43 | 0.28 | 151 |
| Fangfeng | MOL001942 | Isoimperatorin | 45.46 | 0.23 | 1 |
| Fangfeng | MOL011749 | Phelloptorin | 43.39 | 0.28 | 5 |
| Fangfeng | MOL001494 | Mandenol | 42 | 0.19 | 3 |
| Huangqi | MOL000422 | Kaempferol | 41.88 | 0.24 | 62 |
| Fangfeng | MOL002644 | Phellopterin | 40.19 | 0.28 | 12 |
| Fangfeng | MOL007514 | Methyl icosa-11,14-dienoate | 39.67 | 0.23 | 1 |
| Fangfeng | MOL013077 | Decursin | 39.27 | 0.38 | 16 |
| Huangqi | MOL000442 | 1,7-Dihydroxy-3,9-dimethoxy pterocarpene | 39.05 | 0.48 | 4 |
| Fangfeng | MOL011753 | 5-O-Methylvisamminol | 37.99 | 0.25 | 24 |
| Huangqi | MOL000296 | Hederagenin | 36.91 | 0.75 | 22 |
| Fangfeng | MOL000359 | Sitosterol | 36.91 | 0.75 | 3 |
| Fangfeng | MOL000358 | Beta-sitosterol | 36.91 | 0.75 | 37 |
| Huangqi | MOL000379 | 9,10-Dimethoxypterocarpan-3-O- | 36.74 | 0.92 | 3 |
| Fangfeng | MOL003588 | Prangenidin | 36.31 | 0.22 | 15 |
| Huangqi and Baizhu | MOL000033 | (3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 36.23 | 0.78 | 1 |
| Baizhu | MOL000072 | 8 | 35.95 | 0.21 | 5 |
| Fangfeng | MOL001941 | Ammidin | 34.55 | 0.22 | 8 |
| Fangfeng | MOL011747 | Ledebouriellol | 32.05 | 0.51 | 14 |
| Fangfeng | MOL011740 | Divaricatol | 31.65 | 0.38 | 16 |
| Huangqi | MOL000387 | Bifendate | 31.1 | 0.67 | 7 |
| Fangfeng | MOL000173 | Wogonin | 30.68 | 0.23 | 45 |
Figure 1Venn diagram showing the potential NCP targets of Yupingfeng powder.
Figure 2Network diagram of the core targets for Yupingfeng powder.
Network topological characteristics of key compounds and targets.
| Node | Node name | Degree centrality | Betweenness centrality | Closeness centrality |
|---|---|---|---|---|
| C17 | Quercetin | 47 | 0.588 | 0.656 |
| PTGS2 | Prostaglandin G/H synthetase 2 | 32 | 0.305 | 0.621 |
| DPP4 | Dipeptidyl peptidase IV | 20 | 0.101 | 0.526 |
| C32 | Wogonin | 19 | 0.111 | 0.463 |
| C13 | Kaempferol | 18 | 0.075 | 0.453 |
| PTGS1 | Prostaglandin G/H synthetase 1 | 17 | 0.083 | 0.506 |
| NOS2 | Inducible nitric oxide synthetase 2 | 15 | 0.025 | 0.380 |
| PPARG | Peroxisome proliferator activated receptor | 12 | 0.026 | 0.461 |
| NOS3 | Endothelial nitric oxide synthetase | 10 | 0.026 | 0.451 |
Figure 3GO functional analysis.
Figure 4Bubble diagram showing the KEGG pathway analysis.
The binding energy of key active compounds in Yupingfeng powder and 2019 ncov 3CL Hydrolase.
| Target ID | Compounds | Structure | PubChem CID | CAS number | Docking score (kcal/mol) | Combination type |
|---|---|---|---|---|---|---|
| 3CLpro | Kaempferol |
| 5280863 | 520-18-3 | -7.75 | Hydrogen bonds, |
| 3CLpro | Quercetin |
| 5280343 | 117-39-5 | -7.47 | Hydrogen bonds, |
| 3CLpro | Wogonin |
| 5281703 | 632-85-9 | -7.92 | Hydrogen bonds, |
Note: Binding energy function [9–11]: ∆Gbind = Clipo−lipo∑f(T | r) + Chbond−neuto−neut∑g(∆r)h(∆α) + Chbond−charged−charged∑g(∆r)h(∆α) + Cmax−metal−ion∑f(T | m) + CrotbHrotb + Cpolar−phobVpolar−phob + CcoulEcoul + CvdWEvdW + solvationerms. ∆Gbind: binding energy function; Clipo-lipo: the energy sum of the hydrophobic interaction; Chbond-neuto-neut: neutral hydrogen bond interactions; Chbond-charged-charged: the energy sum of charged hydrogen bond interactions; Cmax-metal-ion: the energy sum of the coordination action of metal ions; Crotb Hrotb: rotational bond energy; Cpolar-phobVpolar-phob: polar interaction; CcoulEcoul: electrostatic interaction; CvdWEvdW: Van der Waals force; solvationerms: solvation energy.
Figure 5The binding mode of protein with compound. (a)–(c) The 3D structure for 3CLpro with wogonin, kaempferol, and quercetin. (d)–(f) The detail binding mode 3CLpro with wogonin, kaempferol, and quercetin. The backbone of protein was rendered in tube and colored in green. Compound is rendering by yellow. Yellow dash represents hydrogen bond distance or π-stacking.
Figure 6RMSD plot of molecular dynamic simulations between the protein and compounds.
Figure 7The 3D complex structure of the protein with compounds. (a)–(c) represent 3CLpro with wogonin, kaempferol, and quercetin, respectively.
The analysis of binding energy for target with compound.
| Energy type | Binding free energy/(kcal/mol) | ||
|---|---|---|---|
| Wogonin | Kaempferol | Quercetin | |
| VDW | -27.15 | -26.47 | -29.63 |
| Eele | -22.97 | -28.28 | -31.35 |
| Egb | 30.38 | 23.99 | 21.62 |
| Esurf | -3.87 | -4.11 | -4.29 |
|
| -36.21 | -35.97 | -35.4 |
|
| 25.23 | 24.23 | 20.23 |
|
| -15.49 | -15.61 | -18.91 |
Hydrogen bond interaction parameters for target with wogonin.
| Atom | Residues | Bond distance/(Å) | Bond angle/(°) | Proportion/(%) |
|---|---|---|---|---|
| O3 | MET-49 | 2.92 | 143.38 | 1.13 |
| O5 | LEU-141 | 2.90 | 145.23 | 36.48 |
| O3 | CYS-44 | 2.88 | 153.17 | 1.39 |
| O3 | GLN-192 | 2.87 | 140.11 | 0.97 |
| O3 | GLU-166 | 2.84 | 149.23 | 41.24 |
| O5 | LEU-167 | 2.71 | 150.01 | 1.48 |
| O4 | ASP-187 | 2.65 | 138.76 | 1.32 |
Hydrogen bond interaction parameters for target with kaempferol.
| Atom | Residues | Bond distance/(Å) | Bond angle/(°) | Proportion/(%) |
|---|---|---|---|---|
| O5 | GLU-166 | 2.96 | 140.32 | 13.25 |
| O3 | ASP-187 | 2.86 | 148.25 | 1.20 |
| O2 | MET-49 | 2.85 | 154.14 | 1.38 |
| O3 | LEU-167 | 2.74 | 142.45 | 0.97 |
| O2 | THR-190 | 2.71 | 147.21 | 3.11 |
| O6 | CYS-44 | 2.63 | 143.52 | 1.15 |
| O5 | LEU-141 | 2.59 | 156.47 | 2.23 |
| O6 | TYR-54 | 2.48 | 150.59 | 35.43 |
| O5 | GLN-189 | 2.48 | 152.43 | 1.93 |
| O4 | GLN-192 | 2.37 | 139.78 | 35.22 |
Hydrogen bond interaction parameters for target with quercetin.
| Atom | Residues | Bond distance/(Å) | Bond angle/(°) | Proportion/(%) |
|---|---|---|---|---|
| O6 | CYS-44 | 3.00 | 156.71 | 3.13 |
| O7 | GLN-189 | 2.86 | 153.58 | 2.78 |
| O2 | THR-190 | 2.84 | 147.11 | 3.25 |
| O3 | LEU-167 | 2.81 | 150.19 | 1.02 |
| O2 | MET-49 | 2.74 | 147.25 | 0.75 |
| O7 | LEU-141 | 2.74 | 160.24 | 1.09 |
| O4 | GLN-192 | 2.73 | 148.29 | 36.43 |
| O7 | ASP-187 | 2.71 | 140.32 | 0.87 |
| O3 | TYR-54 | 2.62 | 152.65 | 27.34 |
| O5 | GLU-166 | 2.59 | 154.21 | 15.76 |